What is the chance of offspring inheriting alpha thalassemia trait from a mother with alpha thalassemia trait and a father without the trait?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 3, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Alpha Thalassemia Inheritance Risk

When a mother has alpha thalassemia trait and the father has no trait, each offspring has a 50% chance of inheriting the alpha thalassemia trait and a 50% chance of being completely unaffected—there is no risk of severe disease.

Genetic Inheritance Pattern

Alpha thalassemia trait typically involves deletion of one or two alpha-globin genes (out of four total). The inheritance follows autosomal recessive patterns 1, 2:

  • If the mother is a silent carrier (one gene deletion: -α/αα), each child has:

    • 50% chance of inheriting the deletion (becoming a silent carrier)
    • 50% chance of inheriting normal genes (no trait)
    • 0% risk of clinically significant disease 3
  • If the mother has alpha thalassemia trait (two gene deletions: --/αα or -α/-α), each child has:

    • 50% chance of inheriting one deleted chromosome (becoming a carrier with one or two gene deletions)
    • 50% chance of inheriting the normal chromosome (no trait or silent carrier)
    • 0% risk of Hemoglobin H disease or Bart's hydrops fetalis 1, 4

Why Severe Disease Cannot Occur

The critical point is that the father contributes two normal alpha genes on each chromosome, which prevents any severe forms of alpha thalassemia 3:

  • Hemoglobin H disease requires three gene deletions (only possible if both parents are carriers) 4
  • Hemoglobin Bart's hydrops fetalis requires four gene deletions (only possible if both parents have two-gene deletions) 5, 3
  • Since the father has no trait, he can only contribute normal alpha genes 1

Clinical Implications for Offspring

Children who inherit the trait will be asymptomatic and require no treatment 2, 3:

  • Silent carriers and those with alpha thalassemia trait have normal life expectancy 3
  • They will have microcytic red blood cells (MCV <80 fL) with normal or elevated RBC count 6
  • No monitoring or treatment is needed 2
  • The only clinical significance is for their own future reproductive planning 1

Essential Counseling Points

Genetic counseling should emphasize that this couple faces no risk of having a child with severe alpha thalassemia 6:

  • Partner testing confirmed the father is not a carrier, which is reassuring 6
  • Future pregnancies carry the same 50/50 risk pattern with no severe disease risk 1
  • Children who inherit the trait should receive genetic counseling before their own reproductive planning 1, 5
  • Cascade testing of other family members on the maternal side may be appropriate 5

Common Pitfall to Avoid

Do not confuse this scenario with situations where both parents are carriers—that is when severe disease becomes possible 6, 3:

  • The 25% risk of severe disease only applies when both parents carry alpha thalassemia mutations 6
  • In this case, with only one parent affected, the maximum number of gene deletions possible in offspring is two (trait), not three or four (severe disease) 4

References

Guideline

Newborn Testing for Alpha Thalassemia When Mother is a Carrier

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Alpha- and Beta-thalassemia: Rapid Evidence Review.

American family physician, 2022

Research

Alpha and beta thalassemia.

American family physician, 2009

Research

The Clinical Phenotypes of Alpha Thalassemia.

Hematology/oncology clinics of North America, 2023

Guideline

Alpha Thalassemia Diagnosis and Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Prenatal Workup for Thalassemia

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.